The TROPION-Breast01 phase III study shows that while the ADC datopotamab deruxtecan (Dato-DXd) improves progression-free survival, it does …
The TROPION-Breast01 phase III study shows that while the ADC datopotamab deruxtecan (Dato-DXd) improves progression-free survival, it does …
With increasing geopolitical disruptions and shifting trial strategies, India emerges as an attractive destination for early-stage clinical trials, …
Grace Therapeutics reports that its Phase III STRIVE-ON trial showed GTx-104 significantly reduces clinically significant hypotension and improves …
Acadia Pharmaceuticals advances its serotonin 5-HT₂A inverse agonist, remlifanserin (ACP-204), into the final phases of clinical testing as …
A pioneering personalized cancer vaccine, designed using tumor-specific neoantigens, has achieved remission in all nine advanced kidney cancer …
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) modernizes its clinical trial framework with major updates to …
New clinical-stage anti-obesity therapies began breaking ground—designed not just to shed pounds, but to retain muscle, offering a …
Uvax Bio elevated Chief Business Officer Kevin O’Neill to Interim CEO following the departure of Ji Li, Ph.D., …
Novartis confirmed its acquisition of Anthos Therapeutics for up to $3.1 billion—securing a promising Phase III-stage anticoagulant aimed at …